Automatic untargeted metabolic profiling analysis coupled with Chemometrics for improving metabolite identification quality to enhance geographical origin discrimination capability
Lu Han(Songjiang District Central Hospital), Yuanbin She(Zhejiang University of Technology), Changcai Bai(Ningxia Medical University), Yong‐Jie Yu(Ningxia University), Qiansi Chen(China Tobacco), Qingxia Zheng(Broad Institute), Yueming Zhang(Shaanxi Science and Technology Department), Meijuan Fan(Tobacco Research Institute), Pingping Liu(Tobacco Research Institute), Jingjing Song(Chongqing Metrology Quality Inspection and Research Institute), Tao Sun(Wuhan University)
Cited by 21
Related Papers
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
Amivantamab plus Lazertinib in Previously Untreated <i>EGFR</i> -Mutated Advanced NSCLC
|New England Journal of Medicine|2024|369
MONARCH plus: abemaciclib plus endocrine therapy in women with HR+/HER2– advanced breast cancer: the multinational randomized phase III study
|Therapeutic Advances in Medical Oncology|2020|110